Table 3.
Univariate HR (95% CI) |
p | Multivariatea
HR (95% CI) |
p | |
---|---|---|---|---|
At 30-day follow-up | ||||
Body mass indexb | 0.98 (0.95–1.01) | 0.258 | 0.98 (0.94–1.02) | 0.374 |
Normal weight vs. overweight | 0.70 (0.50–0.98) | 0.038 | 0.68 (0.45–0.95) | 0.027 |
Normal weight vs. obese | 0.79 (0.54–1.17) | 0.237 | 0.81 (0.50–1.29) | 0.370 |
Overweight vs. obese | 1.13 (0.74–1.72) | 0.583 | 1.18 (0.71–1.96) | 0.520 |
At 1‑year follow-up | ||||
Body mass indexb | 0.98 (0.94–1.01) | 0.189 | 0.97 (0.94–1.02) | 0.217 |
Normal weight vs. overweight | 0.65 (0.47–0.91) | 0.013 | 0.69 (0.43–0.88) | 0.009 |
Normal weight vs. obese | 0.74 (0.50–1.10) | 0.136 | 0.70 (0.43–1.12) | 0.133 |
Overweight vs. obese | 1.14 (0.75–1.74) | 0.547 | 1.19 (0.72–1.96) | 0.497 |
HR hazard ratio, CI confidence interval
aAdjusted for: age, gender, New York Heart Association (NYHA) class ≥ III, diabetes mellitus, hypertension, dyslipidaemia, left ventricular ejection fraction (LVEF), calcium channel blockers, beta blockers, antiarrhythmics, diuretics, angiotensin II receptor blockers, aspirin, lipid-lowering agents, insulin, periprosthetic aortic valve regurgitation (PPR) ≥mild, postoperative delirium, hospital stay
bAs a continuous variable